About 1 200 reports

  • 1.4 Allergy Immunotherapy
  • 3. Allergy Immunotherapy Market Analysis

Global Allergy Immunotherapy Market: Industry Analysis & Outlook (2019- 2023) ##.

  • Immunotherapy
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies.

  • Allergy Immunotherapy
  • Immunotherapy
  • Medical Biotechnology
  • World
  • Market Size

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis ##.

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • World
  • Overview: Immunotherapy
  • Market segmentation by type of immunotherapy

Examples of immunotherapy drugs that target PD- ## include nivolumab (Opdivo) and pembrolizumab (Keytruda).

  • Immunotherapy
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

Allergy Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 Chapter ## Preface ##. ##.

  • Allergy Immunotherapy
  • Immunotherapy
  • APAC
  • World
  • Market Size
  • 4.2 Pipeline by Stage of Development, Molecule Type, Route of Administration and Program Type

A prime example of this is the emergence of immunotherapies and PD-##/ PD-L## targeted agents.

  • Immunotherapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • 3.5.1.2. PASSIVE IMMUNOTHERAPY
  • 3.5.1.1. ACTIVE IMMUNOTHERAPY

IMMUNOTHERAPIES ARE KNOWN TO PROVIDE THERAPEUTIC BENEFITS BY ONE OF THE FOLLOWING MECHANISMS: MOREOVER, IMMUNOTHERAPY MAY PREVENT RECURRENCE OF TUMOR POST-SURGERY.

  • Immunotherapy
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

Immunotherapy Drugs Market by Type, by Therapy Area, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023 Chapter ##.

  • Immunotherapy
  • Medical Biotechnology
  • World
  • Demand
  • Forecast

Global T-Cell Immunotherapy Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments Chapter ##.

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • World
  • STAGE OF DEVELOPMENT PRECLINICAL IND/CTA-FILED PHASE I PHASE II PHASE III PRE-REGISTRATION
  • Versatile Innovation in Hematological Cancers Therapeutics Market, Global, Pipeline by Stage of Development and Molecule Type,

Immunotherapy, which includes chemotherapy, has revolutionized cancer treatment.

  • Immunotherapy
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Juno Therapeutics Inc.
  • Novartis AG
  • Overview: Immunotherapy
  • Market segmentation by type of immunotherapy

Examples of immunotherapy drugs that target PD- ## include nivolumab (Opdivo) and pembrolizumab (Keytruda).

  • Immunotherapy
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • 8.1.1 PEANUT IMMUNOTHERAPIES
  • 6.3.4 PEANUT DESENSITIZATION USING EXPERIMENTAL ORAL IMMUNOTHERAPY

ONE OF THE MAIN BARRIERS TO THE SUCCESS OF PEANUT IMMUNOTHERAPIES THERAPIES IS THE QUESTION OF HOW THEY WILL BE REIMBURSED.

  • Immunotherapy
  • Australia
  • World
  • Forecast
  • Aimmune Therapeutics, Inc.

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources

  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Forecast
  • Market Size
  • IMMUNOTHERAPIES' - PD-1 INHIBITORS UPTAKE, U.S., 2016

TOPICAL IMMUNOTHERAPY AND VASODILATORS: TOPICAL IMMUNOTHERAPY IS ONE OF THE BEST TREATMENTS SO FAR FOR SEVERE AND REFRACTORY ALOPECIA AREATA.

  • Immunotherapy
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • T-cell Immunotherapy: An Introduction1
  • T-cell Immunotherapy Number of Molecules in Preclinical Development

Note on Confidentiality Contents T-cell Immunotherapy: An Introduction ## ## Market Overview Market Forecast: Scenario Comparison T-cell Immunotherapy: An Introduction## Growing Clinical Pipeline The Primary Growth Driver With no marketed products, this emerging field is still in its

  • Immunotherapy
  • Medical Biotechnology
  • United States
  • Market Size
  • Kite Pharma, Inc.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

Immunotherapy to prevent certain types of pneumonia is available.

  • Immunotherapy
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

The auto exports exceeded over ## million each year.

  • Immunotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Immunotherapy Drugs Sales Volume (million Yuan)
  • Immunotherapy Drugs Sales Volume by Drugs Classification in 2017(percent)

The auto exports exceeded over ## million each year.

  • Immunotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • 8.3 IMMUNOTHERAPIES
  • These drugs are classified into two groups: immunotherapies and molecular-targeted

US KEY OPINION LEADER CURRENTLY, THERE IS ONLY ONE LATE-STAGE IMMUNOTHERAPY IN THE PIPELINE THAT TARGETS MSS PATIENTS, ROCHE' S TECENTRIQ.

  • Immunotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Immunotherapy ##.

  • Immunotherapy
  • Medical Biotechnology
  • APAC
  • World
  • Market Size

Global Tumor-specific Antigen Market Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Technology Background Market O

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Forecast
  • 7.2.3 LIMITED INCORPORATION OF IMMUNOTHERAPIES IN THE CRC TREATMENT ALGORITHM
  • 5.1.2 FAILURE RATE BY PHASE AND MOLECULE TYPE

Nivolumab as Programmed Death-## (PD-##) Inhibitor for Targeted Immunotherapy in Tumor.

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Market Size
  • Merck & Co., Inc.

The combined sales from both segments are expected to make up for nearly one-third of the market, with a combined sales value of $## billion in 2021.

  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World
  • Forecast
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

Immunotherapy to prevent certain types of pneumonia is available.

  • Immunotherapy
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Zhejiang Expressway Co., Ltd.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

Immunotherapy Drugs Sales Volume α-Interferon Sales Volume ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Zhejiang Beisheng Medicine Industry Hansheng Pharmaceutical Co., Ltd.

  • Immunotherapy
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Shenyang Sunshine Pharmaceutical Co., Ltd.
  • Immunotherapy Drugs Sales Volume (million Yuan)
  • Immunotherapy Drugs Sales Volume by Drugs Classification in 2017(percent)

Chapter IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Chart ##: Immunotherapy Drugs Sales Volume (million Yuan) The Immunotherapy Drugs contains two different kinds, and they are cytokines and cancer vaccines.

  • Immunotherapy
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Yantai Ausbio Biotech Co., Ltd
  • Nov 29, 2017: ACRF grant to transform Queensland into global immunotherapy hub
  • Jul 06, 2018: Hope for transplant patients after world-first Queensland immunotherapy trial

The study will be funded by NIAID and bring the vaccine one step closer.

  • Hospital
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Social Conditions
  • T-CELL IMMUNOTHERAPY PIPELINE
  • CELLECTIS:T-CELL IMMUNOTHERAPY COLLABORATIONS

ONE OF THE CURRENT FOCUS AREAS IS IMMUNOTHERAPY, WHICH MAKES USE OF THE BODY' S OWN IMMUNE SYSTEM OR ITS COMPONENTS TO FIGHT CANCER.

  • Immunotherapy
  • North America
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • NON-SPECIFIC IMMUNOTHERAPIES
  • GLOBAL NON-SPECIFIC IMMUNOTHERAPIES MARKET

In May 2015, the company and Merck expanded their collaboration to evaluate the efficacy and safety of T-VAC (its investigational oncolytic immunotherapy) in combination with Keytruda (Merck' s anti-PD-## therapy), in Phase ##, open-label trial of people with recurrent o

  • Immunotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Future use of immunotherapy
  • Future use of immunotherapy

" I' ve seen trials combining immunotherapy, immunotherapy chemo combinations, or immunotherapy with targeted therapy.

  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • European Union
  • United States